生物反增强认知行为疗法几乎向患有炎症性肠道疾病的青少年提供:随机对照试验
Kelly Rea1, Abigail Robbertz2, Adrianna Westbrook3
1Division of Pediatric Psychology, Department of Pediatrics, Michigan Medicine, Ann Arbor, MI, USA.
Inflammatory bowel diseases
|April 29, 2025
概括
这项研究发现,使用心率变化 (HRV) 的虚拟应对技能计划,生物反对于患有炎症性肠道疾病 (IBD) 的年轻人来说是可行的和可以接受的. 它有效地减少了焦虑,抑郁和胃肠道症状.
科学领域:
- 心理神经免疫学 心理神经免疫学
- 儿科胃肠病学 儿科胃肠病学
- 行为医学是一种行为医学.
背景情况:
- 炎症性肠病 (IBD) 越来越多地与大脑-肠轴功能障碍和慢性压力有关.
- 了解压力反应系统在IBD中的作用,对于开发有效的治疗方法至关重要.
- 针对心理和生理压力标志物可能会改善IBD青少年的结果.
研究的目的:
- 评估对IBD青少年进行虚拟群体干预的可行性,可接受性和初步疗效.
- 干预组合了认知行为疗法 (CBT) 与心率变化 (HRV) 生物反.
- 关键目标包括减少焦虑,抑郁,胃肠道 (GI) 症状和感知压力.
主要方法:
- 一项随机对照试验,涉及53名患有IBD的年轻人 (年龄13-18岁) 和他们的护理人员.
- 参与者被分配到即时治疗或等候名单对照组.
- 该干预包括每周6次虚拟小组会议,重点关注应对技巧,CBT和HRV生物反.
主要成果:
- 该干预表明了高可行性 (84%的出席率) 和可接受性,参与者和家长的满意度很高.
- 与对照组相比,家长报告了青少年抑郁症状,焦虑和胃肠道症状的显著减少.
- 青少年报告胃肠道症状和感知压力的减少,以及治疗组内的焦虑减少;没有观察到HRV变化.
结论:
- 这项试点研究表明,对患有IBD的青少年来说,虚拟的,基于小组的HRV生物反干预是可行的和可以接受的.
- 初步证据表明,它有助于缓解与IBD相关的心理和身体症状.
- 未来的研究应该专注于更大,多样化的样本,具有更高的基线心理症状水平,以进一步验证疗效.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Irritable Bowel Syndrome III: Medical and Nursing Management
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
Irritable Bowel Syndrome
DefinitionIrritable bowel syndrome (IBS) is a functional gastrointestinal disorder characterized by recurrent combinations of abdominal pain, bloating, diarrhea, or constipation.Pathophysiology of irritable bowel syndromeIts pathophysiology is multifactorial, involving disturbances in motility, sensory processing, microbial balance, barrier integrity, and gut–brain communication. These mechanisms interact to produce symptoms that vary across IBS subtypes.Altered Motility PatternsDisordered...


